Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of patients with chronic cough in ...

Meanwhile, Prevail Therapeutics is developing a gene therapy for a form of Parkinson's that is caused by mutations in the GBA1 gene, and Aspen Neuroscience is working on a personalised stem cell ...

Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial HighlightsLast patient recruited in the NCX 470 (bimatoprost ...

Press Release Nicox Announces Scientific Presentation and Conference Attendance in H1 2025January 28, 2025 – release at 7:30 am CETSophia ...

Net sales grew +12% (cc 1, +11% USD) with core operating income 1 up +22% (cc, +19% USD) Sales growth driven by continued st ...

The publication reviews the results of 204 patients with 12 tumor types enrolled and treated on the eNRGy study, concluding “Zenocutuzumab demonstrated durable efficacy in patients with advanced NRG1+ ...

GPCR Therapeutics and NAMS were highlighted for their potential indirect catalysts, with the former's GSBR-1290 and the latter's obicetrapib's Phase 3 PREVAIL CVOT noted for their potential impacts.

Others include a partnership between Biogen and Sangamo and Eli Lilly's $1 billion takeover of Prevail in 2020 ... drug developers including Gain Therapeutics, MODAG, and Alterity Therapeutics.

Novartis acquired Kate Therapeutics, a preclinical-stage biotechnology ... If late-January exchange rates prevail for the remainder of 2025, the foreign exchange impact for the year would be ...

EAU CLAIRE, Wis. (WEAU) - A car crashed into Prevail Bank on Fairfax Street by HyVee Friday evening. Our photojournalist on scene saw the car almost completely in the building with a tow truck pulling ...